The circadian clock gene per1 suppresses cancer cell proliferation and tumor growth at specific times of day

Chronobiology International

Volumn 26, Issue 7, 2009, Pages 1323-1339

  Yang, Xiaoming ^a   Wood, Patricia A ^a,b   Ansell, Christine M ^a   Quiton, Dinah Faith T ^a,c   Oh, Eun Yeong ^a,b   Du Quiton, Jovelyn ^a   Hrushesky, William J M ^a,b,c  

^a WJB Dorn VA Medical Center   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Clock gene; Per1; Tumor growth; Tumor suppression

Indexed keywords

PER1 PROTEIN; PER2 PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CIRCADIAN RHYTHM; DOWN REGULATION; FEMALE; GENE EXPRESSION; IN VITRO SELECTION; IN VIVO STUDY; LIVER; MOUSE; NONHUMAN; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; CIRCADIAN RHYTHM; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; HUMANS; LIVER; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; PERIOD CIRCADIAN PROTEINS; PHOTOPERIOD; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSFECTION;

MAMMALIA;

EID: 70450209086     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420520903431301     Document Type: Article

References (35)

1. Albrecht U, Zheng B, Larkin D, Sun ZS, Lee CC. (2001). MPer1 and mper2 are essential for normal resetting of the circadian clock. J. Biol. Rhythms 16:100-104. (Pubitemid 32391905)
2. Bae K, Jin X, Maywood ES, Hastings MH, Reppert SM, Weaver DR. (2001). Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron 30:525-536.
3. Bjarnason GA, Jordan RC, Wood PA, Li Q, Lincoln DW, Sothern RB, Hrushesky WJ, Ben-David Y. (2001). Circadian expression of clock genes in human oral mucosa and skin: Association with specific cell-cycle phases. Am. J. Pathol. 158:1793-1801.
4. Dardente H, Cermakian N. (2007). Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol. Int. 24:195-213.
5. Devroe E, Silver PA. (2002). Retrovirus-delivered siRNA. BMC Biotechnol. 2:15-19.
6. Fu L, Lee CC. (2003). The circadian clock: Pacemaker and tumour suppressor. Nat. Rev. Cancer 3:350-361.
7. Fu L, Pelicano H, Liu J, Huang P, Lee C. (2002). The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111:41-50.
8. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP. (2006). The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol. Cell. 22:375-382.
9. Grechez-Cassiau A, Rayet B, Guillaumond F, Teboul M, Delaunay F. (2008). The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J. Biol. Chem. 283:4535-4542.
10. Hrushesky WJ. (1985). Circadian timing of cancer chemotherapy. Science 228:73-75.
11. Hrushesky WJ, Lester B, Lannin D. (1999). Circadian coordination of cancer growth and metastatic spread. Int. J. Cancer 83:365-373.
12. Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang C, Wang X, Wang Z, Cornelissen-Guillaume G, Halberg F. (2006). Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci. 97:589-596.
13. Hua H, Wang Y, Wan C, Liu Y, Zhu B, Wang X, Wang Z, Ding JM. (2007). Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice. Cancer Gene Ther. 14:815-818.
14. James FO, Boivin DB, Charbonneau S, Bélanger V, Cermakian N. (2007). Expression of clock genes in human peripheral blood mononuclear cells throughout the sleep/wake and circadian cycle. Chronobiol. Int. 24:1099-11034
15. Kobayashi M, Wood PA, Hrushesky WJ. (2002). Circadian chemotherapy for gynecological and genitourinary cancers. Chronobiol. Int. 19:237-251.
16. Lee C, Etchegaray JP, Cagampang FR, Loudon AS, Reppert SM. (2001). Posttranslational mechanisms regulate the mammalian circadian clock. Cell 107:855-867. (Pubitemid 34084977)
17. Liu S, Cai Y, Sothern RB, Guan Y, Chan P. (2007). Chronobiologic analysis of circadian patterns in transcription of seven key clock genes in six peripheral tissues in mice. Chronobiol. Int. 24:793-820.
18. Maltsev VA, Lakatta EG. (2007). Normal heart rhythm is initiated and regulated by an intracellular calcium clock within pacemaker cells. Heart Lung Circ. 16:335-348.
19. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. (2003). Control mechanism of the circadian clock for timing of cell division in vivo. Science 302:255-259.
20. Miller BH, McDearmon EL, Panda S, Hayes KR, Zhang J, Andrews JL, Antoch MP, Walker JR, Esser KA, Hogenesch JB, Takahashi JS. (2007). Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc. Natl. Acad. Sci. USA 104:3342-3347.
21. Motzkus D, Loumi S, Cadenas C, Vinson C, Forssmann WG, Maronde E. (2007). Activation of human period-1 by PKA or CLOCK/BMAL1 is conferred by separate signal transduction pathways. Chronobiol Int. 24:783-792.
22. Portaluppi F, Touitou Y, Smolensky MH. (2008). Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol. Int. 25:999-1016.
23. Reppert SM, Weaver DR. (2002). Coordination of circadian timing in mammals. Nature 418:935-941.
24. Schrem H, Klempnauer J, Borlak J. (2002). Liver-enriched transcription factors in liver function and development, part I: The hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol. Rev. 54:129-158.
25. Schrem H, Klempnauer J, Borlak J. (2004). Liver-enriched transcription factors in liver function and development, part II: The C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacol. Rev. 56:291-330.
26. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE. (2006). The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274.
27. Smaaland R, Laerum OD, Lote K, Sletvold O, Sothern RB, Bjerknes R. (1991). DNA synthesis in human bone marrow is circadian stage dependent. Blood 77:2603-2611.
28. Smolensky MH, Peppas NA. (2007). Chronobiology, drug delivery, and chronotherapeutics. Adv. Drug Deliv. Rev. 59:828-851.
29. Vansteensel MJ, Michel S, Meijer JH. (2008). Organization of cell and tissue circadian pacemakers: A comparison among species. Brain Res. Rev. 58:18-47.
30. Wood PA, Hrushesky WJ, Klevecz R. (1998). Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics. Exp. Hematol. 26:523-533.
31. Wood PA, Du-Quiton J, You S, Hrushesky WJ. (2006). Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol. Cancer Ther. 5:2023-2033.
32. Wood PA, Yang X, Taber A, Oh EY, Ansell C, Ayers SE, Al-Assaad Z, Carnevale K, Berger FG, Pena MM, Hrushesky WJ. (2008). Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol. Cancer Res. 6:1786-1793.
33. Yamamoto T, Nakahata Y, Soma H, Akashi M, Mamine T, Takumi T. (2004). Transcriptional oscillation of canonical clock genes in mouse peripheral tissues. BMC Mol. Biol. 5:18.
34. Yang X, Wood PA, Oh EY, Du-Quiton J, Ansell CM, Hrushesky WJ. (2009). Down-regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res. Treat. 117:423-431.
35. You S, Wood PA, Xiong Y, Kobayashi M, Du-Quiton J, Hrushesky WJ. (2005). Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res. Treat. 91:47-60.